Overview

ELI in TBI 24 Hour

Status:
NOT_YET_RECRUITING

Trial end date:
2031-07-01

Target enrollment:

Participant gender:

Summary

This is a safety phase 2 clinical trial of intravenous infusion of sodium lactate in patients with severe TBI. This study is intended for patients in the acute setting in an intensive care unit at centers that have been selected to participate in this trial. This is a proof of safety study and biomarker response study.

Phase:

PHASE2

Details

Lead Sponsor:

University of California, Los Angeles

Treatments:

Sodium Chloride
Sodium Lactate